Versigent (NYSE:VGNT) Director Kevin Clark Sells 49,517 Shares of Company Stock

Posted by Brian Himes on Oct 10th, 2026

Versigent (NYSE:VGNT – Get Free Report) Director Kevin Clark sold 49,517 shares of the business’s stock in a transaction dated Wednesday, October 7th. The stock was sold at an average price of $45.00, for a total value of $2,228,265.00. Following the sale, the director owned 75,332 shares in the company, valued at approximately $3,389,940. The trade was a 39.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Versigent Price Performance

VGNT stock opened at $44.31 on Friday. Versigent has a 52-week low of $26.34 and a 52-week high of $50.88. The company’s 50 day moving average price is $46.37. The company has a debt-to-equity ratio of 7.29, a current ratio of 1.40 and a quick ratio of 1.09. The firm has a market capitalization of $3.14 billion and a price-to-earnings ratio of 23.08.

Versigent (NYSE:VGNT – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.34. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.29 billion. Sell-side analysts predict that Versigent will post 7.23 EPS for the current fiscal year.

Versigent Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Friday, September 4th were issued a $0.13 dividend. The ex-dividend date was Friday, September 4th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.2%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on VGNT shares. TD Cowen lifted their price target on Versigent from $49.00 to $58.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Evercore reissued an “outperform” rating and issued a $65.00 price objective on shares of Versigent in a research note on Monday, August 10th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $54.00 price objective on shares of Versigent in a research report on Wednesday, August 5th. Oppenheimer set a $50.00 target price on Versigent in a report on Tuesday, July 21st. Finally, The Goldman Sachs Group reduced their price target on shares of Versigent from $59.00 to $58.00 and set a “buy” rating for the company in a research report on Tuesday. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $53.92.

View Our Latest Report on Versigent

Institutional Trading of Versigent

Several large investors have recently modified their holdings of the company. GAMMA Investing LLC grew its stake in shares of Versigent by 54.8% in the third quarter. GAMMA Investing LLC now owns 2,249 shares of the company’s stock worth $101,000 after acquiring an additional 796 shares during the last quarter. Farther Finance Advisors LLC increased its holdings in Versigent by 53.1% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,052 shares of the company’s stock valued at $47,000 after buying an additional 365 shares during the period. HBK Investments L P acquired a new position in shares of Versigent in the 2nd quarter valued at $14,439,000. Sequoia Financial Advisors LLC bought a new position in shares of Versigent during the 2nd quarter worth about $220,000. Finally, IPG Investment Advisors LLC bought a new position in shares of Versigent during the 2nd quarter worth about $871,000.

About Versigent

(Get Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.